Authors:
Ponec, D
Irwin, D
Haire, WD
Hill, PA
Li, X
McCluskey, ER
Citation: D. Ponec et al., Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: A double-blind placebo-controlled trial - The cardiovascular thrombolytic to open occluded lines (COOL) efficacy trial, J VAS INT R, 12(8), 2001, pp. 951-955
Authors:
Henry, TD
Rocha-Singh, K
Isner, JM
Kereiakes, DJ
Giordano, FJ
Simons, M
Losordo, DW
Hendel, RC
Bonow, RO
Eppler, SM
Zioncheck, TF
Holmgren, EB
McCluskey, ER
Citation: Td. Henry et al., Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease, AM HEART J, 142(5), 2001, pp. 872-880
Citation: Er. Mccluskey, Vascular endothelial growth factor (VEGF) protein therapy for ischemic coronary disease, HANDBOOK OF MYOCARDIAL REVASCULARIZATION AND ANGIOGENESIS, 2000, pp. 119-124